| News

Van Baerle to benefit from Schweizerhalle location

13.11.2018

Next year, chemical company Van Baerle will move from Münchenstein in the canton of Basellandschaft to the Schweizerhalle industrial location. Owner and CEO Daniel Schenk summarized the advantages of the new location in an interview.

Lager Hygieneprodukte, Standort Münchenstein (img. van Baerle)

Van Baerle is leaving Münchenstein after some 130 years because the site is too large for the company, explained Daniel Schenk in an interview. “We have over 20,000 square metres here, while at the new location it will still be around 10,000 square metres.”

But that is not the only reason for staying in the Basel region. Van Baerle is relocating to the chemical and pharmaceutical cluster in Schweizerhalle in the immediate vicinity of companies such as Novartis. Although this proximity was not the decisive factor in favour of the new location, Van Baerle is still set to benefit from it. “We need alkalis for our production – and these are produced in Schweizerhalle,” said Schenk. “We will also be able to exploit synergies in supply with water and steam as well as wastewater.”

The Basel economic development agency proposed the new location to Van Baerle.

For Van Baerle, relocating abroad would not have generated enough advantages. Schenk cited the “solid economic reasons that speak in favour of Switzerland as a business location”. He said that the legal framework in Switzerland enables flexibility and entrepreneurial action and named training and the labour market as other arguments in favour of Switzerland.

Schenk also said that he cannot imagine a Switzerland without industrial activities: “This might be possible for very small countries such as Monaco or Liechtenstein, but not for Switzerland. We have to take care of our workplace.” He added that Swissness will still play a role internationally, even if production costs are lower abroad.

Particularly in the Basel region, the planned reduction in the corporate tax rate is also attractive for the company, even if the privileges of a holding company no longer exist. “The bottom line is that Van Baerle will benefit”, concluded Schenk.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Botanikind settles in Basel
Basel Area Business & Innovation, Innovation, Invest

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Read More
Kinarus secures capital commitment of 57 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Read More
Biotech startups from the Basel Area confirm leading position
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

Read More
T3 Pharma wins Swiss Economic Award
Basel Area Business & Innovation, Innovation, Invest

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Read More
Worg selects Basel Area for European headquarters
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

Read More
ten23 health settles in Basel
Basel Area Business & Innovation, Innovation, Invest

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Read More
Lumineo installs translucent concrete wall for Vinci
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Lumineo installs translucent concrete wall for Vinci

The global construction and energy group Vinci engaged the jurassic Lumineo Group to design a wall made from translucent concrete...

Read More
Roivant invests 200 million dollars in Immunovant
Basel Area Business & Innovation, Innovation, Invest

Roivant invests 200 million dollars in Immunovant

The Basel-based Roivant Group has invested a total of 200 million dollars in the US biopharmaceutical company Immunovant. This investment...

Read More
Lyfegen collaborating with Johnson & Johnson
Basel Area Business & Innovation, Innovation, Invest

Lyfegen collaborating with Johnson & Johnson

The Basel-based startup Lyfegen has developed a platform for value-based healthcare. This should provide improved outcomes for patients and result...

Read More
Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.